1. Home
  2. MDT vs SNY Comparison

MDT vs SNY Comparison

Compare MDT & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medtronic plc.

MDT

Medtronic plc.

HOLD

Current Price

$80.94

Market Cap

105.3B

Sector

Health Care

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$42.87

Market Cap

104.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDT
SNY
Founded
1949
1994
Country
Ireland
France
Employees
N/A
74846
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.3B
104.5B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MDT
SNY
Price
$80.94
$42.87
Analyst Decision
Buy
Buy
Analyst Count
21
5
Target Price
$108.21
$58.00
AVG Volume (30 Days)
11.0M
3.5M
Earning Date
06-03-2026
04-23-2026
Dividend Yield
3.58%
3.47%
EPS Growth
3.32
N/A
EPS
3.73
N/A
Revenue
$36,364,000,000.00
N/A
Revenue This Year
$8.91
$3.49
Revenue Next Year
$6.54
$6.10
P/E Ratio
$21.56
$6.14
Revenue Growth
8.43
N/A
52 Week Low
$73.31
$40.89
52 Week High
$106.33
$52.68

Technical Indicators

Market Signals
Indicator
MDT
SNY
Relative Strength Index (RSI) 53.51 43.39
Support Level $77.62 $42.30
Resistance Level $82.83 $48.76
Average True Range (ATR) 1.70 0.73
MACD 0.16 -0.15
Stochastic Oscillator 59.88 35.86

Price Performance

Historical Comparison
MDT
SNY

About MDT Medtronic plc.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: